Replies to post #3091 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

Good developments, but nothing Earth shattering; notably, there is no mention of an IDX184 partnership.

The IDX184+SoC viral-load data at 50mg qD for 14 days are OK.

IDX316 has evidently been renamed IDX320, unless that’s a typo.

[DewDiligence]

I just noticed that you left out the end of the PR with the financial update.

[DewDiligence]

IDIX ‘ReadMeFirst’ updated:

New clinical data for IDX184;
new clinical data for IDX375;
CTA submitted for IDX320;
updated post on liquidity and cash usage;
updated post on 2010 news flow;
new version of “HCV: Most Likely to Succeed.”

#msg-45382061